JavaScript seems to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.

Human Plasminogen Activator Inhibitor-1 (PAI-1) AssayMax™ELISA Kit

Human Plasminogen Activator Inhibitor-1 (PAI-1) AssayMax™ELISA Kit

Move your mouse over image or click to enlarge

Human Plasminogen Activator Inhibitor-1 (PAI-1) AssayMax™ELISA Kit

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.

View Datasheet

Cat#	Size	Price	Qty	Buy
EP1100-1	96 Well Plate	£276.25

Additional Information

Property	Value or Rating
Manufacturer	Assaypro, LLC.
Product Type	AssayMax™ ELISA Kits
Samples	Serum, Cell Culture, CSF, Tissue Extract
Species	Human
Reactivity	Human
Assay Format	Sandwich ELISA
Product Size	96 Well Plate
Range	0.078-5 ng/ml
Plex Number	1
Storage	Refer to component labels for details
Entrez Gene	5054
Omim	173360
UniProt	P05121
UniGene	Hs.414795, Hs.713079
Special Notes	For Research Use Only, Not To Be Used For Diagnostic Purposes
References	* Oka N et al. (2003) Amiloride and Urinary Trypsin Inhibitor Inhibit Urothelial Cancer Invasion. Eur Urol. 44(6):737-741 * Inoue M et al. (2005) Plasminogen activator inhibitor-1 (PAI-1) gene transfection inhibits the liver metastasis of pancreatic cancer by preventing angiogenesis. Oncol Rep. 14(6):1445-1451 * Drinane MC et al. (2006) Plasminogen and plasmin activity in patients with coronary artery disease. J Thromb Haemost. 4(6):1288-1295 * Roth GA et al. (2006) Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells. Journal of Thrombosis and Haemostasis 4(10):2256-2261 * Yoshida H et al. (2006) Interleukin-1beta enhances the angiotensin-induced expression of plasminogen activator inhibitor-1 through angiotensin receptor upregulation in human astrocytes. Brain Res. 16;1073-1074:38-47 * Katsutani M et al. (2007) Glucose-Based PD Solution, But Not Icodextrin-Based PD Solution, Induces Plasminogen Activator Inhibitor-1 and Tissue-Type Plasminogen Activator in Human Peritoneal Mesothelial Cells via ERK1/2. Therapeutic Apheresis and Dialysis 11(2): 94-100 * Wei JL et al. (2007) Synergistic effects of pravastatin and pioglitazone in renal tubular epithelial cells induced by transforming growth factor-beta1. Cell Biol Int. 31(5):451-458 * Yang CC et al. (2007) In vitro regulation of adipogenesis: tunable engineered tissues. J Tissue Eng Regen Med. 1(2):146-153 * Demirel A et al. (2008) Is Familial Mediterranean Fever a thrombotic disease or not? Eur J Pediatr. 167(3):279-285 * He WJ et al. (2008) Activated protein C ratio, plasma tissue factor activity and activated factor VII in Chinese patients with coronary heart disease. Eur J Med Res. 13:47-51 * Langouche L et al. (2008) Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients. Crit Care Med. 36(5):1475-1480 * Oszajca K et al. (2008) Effect of oxidative stress on the expression of t-PA, u-PA, u-PAR, and PAI-1 in endothelial cells. Biochem Cell Biol. 86(6):477-486 * Sato H et al. (2008) The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma. Molecular Carcinogenesis 47(6):403-409 * Markosyan N and Duffy DM (2009) Prostaglandin E2 acts via multiple receptors to regulate plasminogen-dependent proteolysis in the primate periovulatory follicle. Endocrinology. 150(1):435-44 * Masuko K et al. (2009) A suppressive effect of prostaglandin E2 on the expression of SERPINE1/plasminogen activator inhibitor-1 in human articular chondrocytes: An in vitro pilot study. Open Access Rheumatology Research and Reviews 1: 9-15 * Muto S et al. (2009) INHIBITOR OF PAI-1 PRODUCTION. USPTO Patent Application 20090239868 * Oral B. et al. (2009) Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome. Gynecol Endocrinol 25:110-116 * Tabak O et al. (2009) Hypertension and hemostatic/fibrinolytic balance disorders. Clin Invest Med 32:E285 * Jiang Y et al. (2010) Urokinase-type plasminogen activator system and human cationic antimicrobial protein 18 in serum and induced sputum of patients with chronic obstructive pulmonary disease. Respirology. 15(6):939-946 * Sandra D et al. (2010) Downregulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 by grape seed proanthocyanidin extract. Phytomedicine 17: 42-46 * Sonmez M et al. (2010) Treatment related changes in antifibrinolytic activity in patients with polycythemia vera. Hematology. 15(6):391-339 * Sutoh T et al. (2010) Nafamostat Mesilate (FUT-175) Inhibits Cell Growth and Invasion of Malignant Pleural Mesothelioma Cell Line, MSTO-211H. Hirosaki Med. J. 61:19-25 * Suzuki N et al. (2010) GnRH receptor and peritoneal plasmin activity. Gynecol Endocrinol. 26(9):669-672 * Turfaner N et al. (2010) Ezetimibe Therapy and Its Influence on Oxidative Stress and Fibrinolytic Activity. South Med J. 103:428-433 * Yen GC et al. (2010) Effects of Polyphenolic Compounds on Tumor Necrosis Factor-alpha (TNF-alpha)-Induced Changes of Adipokines and Oxidative Stress in 3T3-L1 Adipocytes. J Agric Food Chem. 59(2):546-551 * Akanji AO et al. (2011) Determinants of blood levels of some thrombogenic biomarkers in healthy Arab adolescent subjects. Clin Chem Lab Med. 49(10):1681-90 * Cenni E et al. (2011) Idiopathic and secondary osteonecrosis of the femoral head show different thrombophilic changes and normal or higher levels of platelet growth factors. Acta Orthopaedica 82 (1): 42-49 * Johansson PI et al. (2011) Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study. Critical Care 15(6):R272 * Krysiak R and Okopien B (2011) Haemostatic effects of simvastatin in subjects with impaired glucose tolerance. Intern Med J. 41(6):473-481 * Mollmark J et al. (2011) Antiangiogenic Activity of rPAI-123 Promotes Vasa Vasorum Regression in Hypercholesterolemic Mice Through a Plasmin-Dependent Mechanism. Circ Res. 108(12):1419-1428 * Ostrowski SR et al. (2011) Thrombelastography and biomarker profiles in acute coagulopathy of trauma: A prospective study. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 19:64 * Ferro M et al. (2012) PLASMATIC SIL 6R/IL-6 RATIO AS A POTENTIAL PREDICTOR OF HIGH GLEASON SUM AT RADICAL PROSTATECTOMY. ANTICANCER RESEARCH 32: 1843-1966 * Johansson PI et al. (2012) High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality. J Thromb Haemost. 10(2):207-216 * Ostrowski SR et al. (2012) High levels of soluble VEGF receptor 1 early after trauma are associated with shock, sympathoadrenal activation, glycocalyx degradation and inflammation in severely injured patients: a prospective study. Scand J Trauma Resusc Emerg Med. 2012 Apr 10;20:27 * Genet GF (2013) Trauma-Induced Coagulopathy: Standard Coagulation Tests, Biomarkers of Coagulopathy, and Endothelial Damage in Patients with Traumatic Brain Injury. J Neurotrauma. 30:301 * Johansson PI et al. (2013) Blood levels of histone-complexed DNA fragments are associated with coagulopathy, inflammation and endothelial damage early after trauma. J Emerg Trauma Shock. 6(3):171-5 * Liu YW et al. (2013) Association of Left Ventricular Longitudinal Strain with Mortality among Stable Hemodialysis Patients with Preserved Left Ventricular Ejection Fraction. Clin J Am Soc Nephrol. 8(9):1564-1574 * Siennicka A et al. (2013) Haemostatic factors and intraluminal thrombus thickness in abdominal aortic aneurysm. Is secondary fibrinolysis relevant? J Physiol Pharmacol. 64(3):321-30 * To M et al. (2013) Sputum Plasminogen Activator Inhibitor-1 Elevation by Oxidative Stress-Dependent Nuclear Factor-?B Activation in COPDPlasminogen Activator Inhibitor-1 Elevation in COPD. Chest. 144(2):515-21 * Akkok B et al. (2014) Pleural effusion and plasma levels of fibrinolytic parameters in tuberculosis pleurisy and contribution to the diagnosis. Eurasian J Pulmonol. 16: 84-88 * Topcuoglu A et al. (2014) Effects of hormone replacement therapy on plasma and tissue fibrinolytic activity in a rat model of surgically induced menopause. Clin Invest Med. 2014 Apr 1;37(2):E85-92 * Tugcu D at al. (2014) Plasma Levels of Plasminogen Activator Inhibitor Type 1 and Vitronectin in Children With Cancer * Wang Y (2014) Association of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene -675 4G/5G and -844 A/G Promoter Polymorphism with Risk of Keloid in a Chinese Han Population. Med Sci Monit. 20:2069-73 * Mousavi M et al. (2015) Effects of Selenium Supplementation on Soluble FMS-Like Tyrosine Kinase-1 and Glutathione Peroxidase Levels and the Plasminogen Activator Inhibitor-1: Plasminogen Activator Inhibitor-2 Ratio in Pregnant Women. Shiraz E-Med J. 16(3): e21596. * Schilder L et al. (2015) Coagulation, fibrinolysis and inhibitors in failing filters during continuous venovenous haemofiltration in critically ill patients with acute kidney injury: effect of anticoagulation modalities. Blood Purif. 39:297-305 (ET1020-1 TAT and EP1100-1 PAI-1 kits). * Ajibola SO et al. (2016) Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy. Nigerian Medical Journal 57 (4):213-216 * Van Epps P et al. (2016) Frailty has a stronger association with inflammation than age in older veterans. Immun Ageing. 2016 Oct 19;13:27. eCollection 2016 * Elci E et al. (2017) Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries. Gynecol Endocrinol. 33(1):43-47. Epub 2016 Jul 16. " title=" * Oka N et al. (2003) Amiloride and Urinary Trypsin Inhibitor Inhibit Urothelial Cancer Invasion. Eur Urol. 44(6):737-741 * Inoue M et al. (2005) Plasminogen activator inhibitor-1 (PAI-1) gene transfection inhibits the liver metastasis of pancreatic cancer by preventing angiogenesis. Oncol Rep. 14(6):1445-1451 * Drinane MC et al. (2006) Plasminogen and plasmin activity in patients with coronary artery disease. J Thromb Haemost. 4(6):1288-1295 * Roth GA et al. (2006) Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells. Journal of Thrombosis and Haemostasis 4(10):2256-2261 * Yoshida H et al. (2006) Interleukin-1beta enhances the angiotensin-induced expression of plasminogen activator inhibitor-1 through angiotensin receptor upregulation in human astrocytes. Brain Res. 16;1073-1074:38-47 * Katsutani M et al. (2007) Glucose-Based PD Solution, But Not Icodextrin-Based PD Solution, Induces Plasminogen Activator Inhibitor-1 and Tissue-Type Plasminogen Activator in Human Peritoneal Mesothelial Cells via ERK1/2. Therapeutic Apheresis and Dialysis 11(2): 94-100 * Wei JL et al. (2007) Synergistic effects of pravastatin and pioglitazone in renal tubular epithelial cells induced by transforming growth factor-beta1. Cell Biol Int. 31(5):451-458 * Yang CC et al. (2007) In vitro regulation of adipogenesis: tunable engineered tissues. J Tissue Eng Regen Med. 1(2):146-153 * Demirel A et al. (2008) Is Familial Mediterranean Fever a thrombotic disease or not? Eur J Pediatr. 167(3):279-285 * He WJ et al. (2008) Activated protein C ratio, plasma tissue factor activity and activated factor VII in Chinese patients with coronary heart disease. Eur J Med Res. 13:47-51 * Langouche L et al. (2008) Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients. Crit Care Med. 36(5):1475-1480 * Oszajca K et al. (2008) Effect of oxidative stress on the expression of t-PA, u-PA, u-PAR, and PAI-1 in endothelial cells. Biochem Cell Biol. 86(6):477-486 * Sato H et al. (2008) The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma. Molecular Carcinogenesis 47(6):403-409 * Markosyan N and Duffy DM (2009) Prostaglandin E2 acts via multiple receptors to regulate plasminogen-dependent proteolysis in the primate periovulatory follicle. Endocrinology. 150(1):435-44 * Masuko K et al. (2009) A suppressive effect of prostaglandin E2 on the expression of SERPINE1/plasminogen activator inhibitor-1 in human articular chondrocytes: An in vitro pilot study. Open Access Rheumatology Research and Reviews 1: 9-15 * Muto S et al. (2009) INHIBITOR OF PAI-1 PRODUCTION. USPTO Patent Application 20090239868 * Oral B. et al. (2009) Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome. Gynecol Endocrinol 25:110-116 * Tabak O et al. (2009) Hypertension and hemostatic/fibrinolytic balance disorders. Clin Invest Med 32:E285 * Jiang Y et al. (2010) Urokinase-type plasminogen activator system and human cationic antimicrobial protein 18 in serum and induced sputum of patients with chronic obstructive pulmonary disease. Respirology. 15(6):939-946 * Sandra D et al. (2010) Downregulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 by grape seed proanthocyanidin extract. Phytomedicine 17: 42-46 * Sonmez M et al. (2010) Treatment related changes in antifibrinolytic activity in patients with polycythemia vera. Hematology. 15(6):391-339 * Sutoh T et al. (2010) Nafamostat Mesilate (FUT-175) Inhibits Cell Growth and Invasion of Malignant Pleural Mesothelioma Cell Line, MSTO-211H. Hirosaki Med. J. 61:19-25 * Suzuki N et al. (2010) GnRH receptor and peritoneal plasmin activity. Gynecol Endocrinol. 26(9):669-672 * Turfaner N et al. (2010) Ezetimibe Therapy and Its Influence on Oxidative Stress and Fibrinolytic Activity. South Med J. 103:428-433 * Yen GC et al. (2010) Effects of Polyphenolic Compounds on Tumor Necrosis Factor-alpha (TNF-alpha)-Induced Changes of Adipokines and Oxidative Stress in 3T3-L1 Adipocytes. J Agric Food Chem. 59(2):546-551 * Akanji AO et al. (2011) Determinants of blood levels of some thrombogenic biomarkers in healthy Arab adolescent subjects. Clin Chem Lab Med. 49(10):1681-90 * Cenni E et al. (2011) Idiopathic and secondary osteonecrosis of the femoral head show different thrombophilic changes and normal or higher levels of platelet growth factors. Acta Orthopaedica 82 (1): 42-49 * Johansson PI et al. (2011) Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study. Critical Care 15(6):R272 * Krysiak R and Okopien B (2011) Haemostatic effects of simvastatin in subjects with impaired glucose tolerance. Intern Med J. 41(6):473-481 * Mollmark J et al. (2011) Antiangiogenic Activity of rPAI-123 Promotes Vasa Vasorum Regression in Hypercholesterolemic Mice Through a Plasmin-Dependent Mechanism. Circ Res. 108(12):1419-1428 * Ostrowski SR et al. (2011) Thrombelastography and biomarker profiles in acute coagulopathy of trauma: A prospective study. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 19:64 * Ferro M et al. (2012) PLASMATIC SIL 6R/IL-6 RATIO AS A POTENTIAL PREDICTOR OF HIGH GLEASON SUM AT RADICAL PROSTATECTOMY. ANTICANCER RESEARCH 32: 1843-1966 * Johansson PI et al. (2012) High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality. J Thromb Haemost. 10(2):207-216 * Ostrowski SR et al. (2012) High levels of soluble VEGF receptor 1 early after trauma are associated with shock, sympathoadrenal activation, glycocalyx degradation and inflammation in severely injured patients: a prospective study. Scand J Trauma Resusc Emerg Med. 2012 Apr 10;20:27 * Genet GF (2013) Trauma-Induced Coagulopathy: Standard Coagulation Tests, Biomarkers of Coagulopathy, and Endothelial Damage in Patients with Traumatic Brain Injury. J Neurotrauma. 30:301 * Johansson PI et al. (2013) Blood levels of histone-complexed DNA fragments are associated with coagulopathy, inflammation and endothelial damage early after trauma. J Emerg Trauma Shock. 6(3):171-5 * Liu YW et al. (2013) Association of Left Ventricular Longitudinal Strain with Mortality among Stable Hemodialysis Patients with Preserved Left Ventricular Ejection Fraction. Clin J Am Soc Nephrol. 8(9):1564-1574 * Siennicka A et al. (2013) Haemostatic factors and intraluminal thrombus thickness in abdominal aortic aneurysm. Is secondary fibrinolysis relevant? J Physiol Pharmacol. 64(3):321-30 * To M et al. (2013) Sputum Plasminogen Activator Inhibitor-1 Elevation by Oxidative Stress-Dependent Nuclear Factor-?B Activation in COPDPlasminogen Activator Inhibitor-1 Elevation in COPD. Chest. 144(2):515-21 * Akkok B et al. (2014) Pleural effusion and plasma levels of fibrinolytic parameters in tuberculosis pleurisy and contribution to the diagnosis. Eurasian J Pulmonol. 16: 84-88 * Topcuoglu A et al. (2014) Effects of hormone replacement therapy on plasma and tissue fibrinolytic activity in a rat model of surgically induced menopause. Clin Invest Med. 2014 Apr 1;37(2):E85-92 * Tugcu D at al. (2014) Plasma Levels of Plasminogen Activator Inhibitor Type 1 and Vitronectin in Children With Cancer * Wang Y (2014) Association of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene -675 4G/5G and -844 A/G Promoter Polymorphism with Risk of Keloid in a Chinese Han Population. Med Sci Monit. 20:2069-73 * Mousavi M et al. (2015) Effects of Selenium Supplementation on Soluble FMS-Like Tyrosine Kinase-1 and Glutathione Peroxidase Levels and the Plasminogen Activator Inhibitor-1: Plasminogen Activator Inhibitor-2 Ratio in Pregnant Women. Shiraz E-Med J. 16(3): e21596. * Schilder L et al. (2015) Coagulation, fibrinolysis and inhibitors in failing filters during continuous venovenous haemofiltration in critically ill patients with acute kidney injury: effect of anticoagulation modalities. Blood Purif. 39:297-305 (ET1020-1 TAT and EP1100-1 PAI-1 kits). * Ajibola SO et al. (2016) Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy. Nigerian Medical Journal 57 (4):213-216 * Van Epps P et al. (2016) Frailty has a stronger association with inflammation than age in older veterans. Immun Ageing. 2016 Oct 19;13:27. eCollection 2016 * Elci E et al. (2017) Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries. Gynecol Endocrinol. 33(1):43-47. Epub 2016 Jul 16. " target="_blank"> * Oka N et al. (2003) Amiloride and Urinary Trypsin Inhibitor Inhibit Urothelial Cancer Invasion. Eur Urol. 44(6):737-741 * Inoue M et al. (2005) Plasminogen activator inhibitor-1 (PAI-1) gene transfection inhibits the liver metastasis of pancreatic cancer by preventing angiogenesis. Oncol Rep. 14(6):1445-1451 * Drinane MC et al. (2006) Plasminogen and plasmin activity in patients with coronary artery disease. J Thromb Haemost. 4(6):1288-1295 * Roth GA et al. (2006) Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells. Journal of Thrombosis and Haemostasis 4(10):2256-2261 * Yoshida H et al. (2006) Interleukin-1beta enhances the angiotensin-induced expression of plasminogen activator inhibitor-1 through angiotensin receptor upregulation in human astrocytes. Brain Res. 16;1073-1074:38-47 * Katsutani M et al. (2007) Glucose-Based PD Solution, But Not Icodextrin-Based PD Solution, Induces Plasminogen Activator Inhibitor-1 and Tissue-Type Plasminogen Activator in Human Peritoneal Mesothelial Cells via ERK1/2. Therapeutic Apheresis and Dialysis 11(2): 94-100 * Wei JL et al. (2007) Synergistic effects of pravastatin and pioglitazone in renal tubular epithelial cells induced by transforming growth factor-beta1. Cell Biol Int. 31(5):451-458 * Yang CC et al. (2007) In vitro regulation of adipogenesis: tunable engineered tissues. J Tissue Eng Regen Med. 1(2):146-153 * Demirel A et al. (2008) Is Familial Mediterranean Fever a thrombotic disease or not? Eur J Pediatr. 167(3):279-285 * He WJ et al. (2008) Activated protein C ratio, plasma tissue factor activity and activated factor VII in Chinese patients with coronary heart disease. Eur J Med Res. 13:47-51 * Langouche L et al. (2008) Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients. Crit Care Med. 36(5):1475-1480 * Oszajca K et al. (2008) Effect of oxidative stress on the expression of t-PA, u-PA, u-PAR, and PAI-1 in endothelial cells. Biochem Cell Biol. 86(6):477-486 * Sato H et al. (2008) The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma. Molecular Carcinogenesis 47(6):403-409 * Markosyan N and Duffy DM (2009) Prostaglandin E2 acts via multiple receptors to regulate plasminogen-dependent proteolysis in the primate periovulatory follicle. Endocrinology. 150(1):435-44 * Masuko K et al. (2009) A suppressive effect of prostaglandin E2 on the expression of SERPINE1/plasminogen activator inhibitor-1 in human articular chondrocytes: An in vitro pilot study. Open Access Rheumatology Research and Reviews 1: 9-15 * Muto S et al. (2009) INHIBITOR OF PAI-1 PRODUCTION. USPTO Patent Application 20090239868 * Oral B. et al. (2009) Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome. Gynecol Endocrinol 25:110-116 * Tabak O et al. (2009) Hypertension and hemostatic/fibrinolytic balance disorders. Clin Invest Med 32:E285 * Jiang Y et al. (2010) Urokinase-type plasminogen activator system and human cationic antimicrobial protein 18 in serum and induced sputum of patients with chronic obstructive pulmonary disease. Respirology. 15(6):939-946 * Sandra D et al. (2010) Downregulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 by grape seed proanthocyanidin extract. Phytomedicine 17: 42-46 * Sonmez M et al. (2010) Treatment related changes in antifibrinolytic activity in patients with polycythemia vera. Hematology. 15(6):391-339 * Sutoh T et al. (2010) Nafamostat Mesilate (FUT-175) Inhibits Cell Growth and Invasion of Malignant Pleural Mesothelioma Cell Line, MSTO-211H. Hirosaki Med. J. 61:19-25 * Suzuki N et al. (2010) GnRH receptor and peritoneal plasmin activity. Gynecol Endocrinol. 26(9):669-672 * Turfaner N et al. (2010) Ezetimibe Therapy and Its Influence on Oxidative Stress and Fibrinolytic Activity. South Med J. 103:428-433 * Yen GC et al. (2010) Effects of Polyphenolic Compounds on Tumor Necrosis Factor-alpha (TNF-alpha)-Induced Changes of Adipokines and Oxidative Stress in 3T3-L1 Adipocytes. J Agric Food Chem. 59(2):546-551 * Akanji AO et al. (2011) Determinants of blood levels of some thrombogenic biomarkers in healthy Arab adolescent subjects. Clin Chem Lab Med. 49(10):1681-90 * Cenni E et al. (2011) Idiopathic and secondary osteonecrosis of the femoral head show different thrombophilic changes and normal or higher levels of platelet growth factors. Acta Orthopaedica 82 (1): 42-49 * Johansson PI et al. (2011) Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study. Critical Care 15(6):R272 * Krysiak R and Okopien B (2011) Haemostatic effects of simvastatin in subjects with impaired glucose tolerance. Intern Med J. 41(6):473-481 * Mollmark J et al. (2011) Antiangiogenic Activity of rPAI-123 Promotes Vasa Vasorum Regression in Hypercholesterolemic Mice Through a Plasmin-Dependent Mechanism. Circ Res. 108(12):1419-1428 * Ostrowski SR et al. (2011) Thrombelastography and biomarker profiles in acute coagulopathy of trauma: A prospective study. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 19:64 * Ferro M et al. (2012) PLASMATIC SIL 6R/IL-6 RATIO AS A POTENTIAL PREDICTOR OF HIGH GLEASON SUM AT RADICAL PROSTATECTOMY. ANTICANCER RESEARCH 32: 1843-1966 * Johansson PI et al. (2012) High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality. J Thromb Haemost. 10(2):207-216 * Ostrowski SR et al. (2012) High levels of soluble VEGF receptor 1 early after trauma are associated with shock, sympathoadrenal activation, glycocalyx degradation and inflammation in severely injured patients: a prospective study. Scand J Trauma Resusc Emerg Med. 2012 Apr 10;20:27 * Genet GF (2013) Trauma-Induced Coagulopathy: Standard Coagulation Tests, Biomarkers of Coagulopathy, and Endothelial Damage in Patients with Traumatic Brain Injury. J Neurotrauma. 30:301 * Johansson PI et al. (2013) Blood levels of histone-complexed DNA fragments are associated with coagulopathy, inflammation and endothelial damage early after trauma. J Emerg Trauma Shock. 6(3):171-5 * Liu YW et al. (2013) Association of Left Ventricular Longitudinal Strain with Mortality among Stable Hemodialysis Patients with Preserved Left Ventricular Ejection Fraction. Clin J Am Soc Nephrol. 8(9):1564-1574 * Siennicka A et al. (2013) Haemostatic factors and intraluminal thrombus thickness in abdominal aortic aneurysm. Is secondary fibrinolysis relevant? J Physiol Pharmacol. 64(3):321-30 * To M et al. (2013) Sputum Plasminogen Activator Inhibitor-1 Elevation by Oxidative Stress-Dependent Nuclear Factor-?B Activation in COPDPlasminogen Activator Inhibitor-1 Elevation in COPD. Chest. 144(2):515-21 * Akkok B et al. (2014) Pleural effusion and plasma levels of fibrinolytic parameters in tuberculosis pleurisy and contribution to the diagnosis. Eurasian J Pulmonol. 16: 84-88 * Topcuoglu A et al. (2014) Effects of hormone replacement therapy on plasma and tissue fibrinolytic activity in a rat model of surgically induced menopause. Clin Invest Med. 2014 Apr 1;37(2):E85-92 * Tugcu D at al. (2014) Plasma Levels of Plasminogen Activator Inhibitor Type 1 and Vitronectin in Children With Cancer * Wang Y (2014) Association of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene -675 4G/5G and -844 A/G Promoter Polymorphism with Risk of Keloid in a Chinese Han Population. Med Sci Monit. 20:2069-73 * Mousavi M et al. (2015) Effects of Selenium Supplementation on Soluble FMS-Like Tyrosine Kinase-1 and Glutathione Peroxidase Levels and the Plasminogen Activator Inhibitor-1: Plasminogen Activator Inhibitor-2 Ratio in Pregnant Women. Shiraz E-Med J. 16(3): e21596. * Schilder L et al. (2015) Coagulation, fibrinolysis and inhibitors in failing filters during continuous venovenous haemofiltration in critically ill patients with acute kidney injury: effect of anticoagulation modalities. Blood Purif. 39:297-305 (ET1020-1 TAT and EP1100-1 PAI-1 kits). * Ajibola SO et al. (2016) Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy. Nigerian Medical Journal 57 (4):213-216 * Van Epps P et al. (2016) Frailty has a stronger association with inflammation than age in older veterans. Immun Ageing. 2016 Oct 19;13:27. eCollection 2016 * Elci E et al. (2017) Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries. Gynecol Endocrinol. 33(1):43-47. Epub 2016 Jul 16.

Related Documents